Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-sarcoglycan is a transmembrane protein encoded by the SGCA gene in humans. It is a critical component of the sarcoglycan complex, which forms part of the dystrophin-glycoprotein complex (DGC) in muscle cell membranes. The DGC links the intracellular actin cytoskeleton to the extracellular matrix, maintaining muscle fiber integrity. Mutations in SGCA cause limb-girdle muscular dystrophy type 2D (LGMDR3), characterized by progressive muscle weakness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-sarcoglycan (SGCA).